Orthocell Ltd
ASX:OCC
Orthocell Ltd
ASX:OCC
Price:
0.895
AUD
-0.56%
Market Cap:
AU$242.8m
Relative Value
The Relative Value of one
OCC
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 0.895 AUD,
Orthocell Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
OCC Relative Value
HIDDEN
Multiples Across Competitors
OCC Competitors Multiples
Orthocell Ltd Competitors
Orthocell Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Orthocell Ltd
ASX:OCC
|
242.8m AUD | 26.3 | -28.3 | -18.3 | -18.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
417.5B USD | 6.8 | 99.9 | 16.3 | 22.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.7B USD | 5.6 | 26.5 | 15.2 | 15.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.3B USD | 6.3 | 21.7 | 13.5 | 16.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.5B USD | 10.1 | 30.7 | 23.2 | 24.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD | 5.8 | 18.5 | 13.9 | 15.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.1B AUD | 3.2 | 35.7 | 11.7 | 14.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.3B EUR | 11.2 | 35.8 | 39 | 39.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
